Literature DB >> 23362970

Allergic rhinitis is often undiagnosed and untreated: results from a general population study of Danish adults.

Christian Grønhøj Larsen1, Mette Gyldenløve, Allan Linneberg.   

Abstract

INTRODUCTION: A few earlier studies have indicated that allergic rhinitis (AR) is underdiagnosed and undertreated.
OBJECTIVE: To assess awareness, diagnosis and treatment of AR in a general population of Danish adults.
METHODS: Between October 2007 and June 2008, a total of 1277 consecutive participants in a Danish general population study of 18- to 69-year olds were skin-prick-tested and asked about respiratory symptoms. AR was defined as a combination of self-reported rhinitis symptoms and skin-prick test reactivity against inhalant allergens. Participants reporting rhinitis symptoms completed an additional questionnaire on medication for rhinitis symptoms.
RESULTS: The prevalence of AR was 23.1%. A total of 43.6% (n = 122/280) of persons with AR had not received any treatment in the previous 12 months, and only 56.6% (n = 163/288) had been given a diagnosis of hay fever by a doctor. Both AR and lower airway symptoms indicating more severe AR were reported in 48.5% (n = 143/295). These persons were significantly more likely to having received treatment in previous 12 months and a diagnosis of hay fever.
CONCLUSION: Our results support that even in an affluent country like Denmark, AR is often undiagnosed and untreated. There appears to be a need for increased awareness of AR with regard to both diagnosis and treatment.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  allergic rhinitis; allergy; prevalence; undertreatment; undiagnosed

Mesh:

Year:  2013        PMID: 23362970     DOI: 10.1111/crj.12015

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  7 in total

Review 1.  How the Smartphone Is Changing Allergy Diagnostics.

Authors:  Ana Margarida Pereira; Cristina Jácome; Rute Almeida; João Almeida Fonseca
Journal:  Curr Allergy Asthma Rep       Date:  2018-10-25       Impact factor: 4.806

2.  Prematurity and prescription asthma medication from childhood to young adulthood: a Danish national cohort study.

Authors:  Anne Louise Damgaard; Bo Mølholm Hansen; René Mathiasen; Frederik Buchvald; Theis Lange; Gorm Greisen
Journal:  PLoS One       Date:  2015-02-04       Impact factor: 3.240

3.  Catching allergy by a simple questionnaire.

Authors:  Maurizio Galimberti; Giovanni Passalacqua; Cristoforo Incorvaia; Vincenzo Castella; Maria Teresa Costantino; Beniamino Cucchi; Sebastiano Gangemi; Gilda Nardi; Paolo Raviolo; Paola Rottoli; Nicola Scichilone; Nico Sciolla; Germano Bettoncelli; Massimo Landi; Erminia Ridolo; Serena Buttafava; Paola Puccinelli; Giorgio Walter Canonica; Alessandro Fiocchi; Franco Frati
Journal:  World Allergy Organ J       Date:  2015-06-11       Impact factor: 4.084

Review 4.  An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel.

Authors:  Brian Lipworth; Jon Newton; Bhaskar Ram; Iain Small; Jürgen Schwarze
Journal:  NPJ Prim Care Respir Med       Date:  2017-01-23       Impact factor: 2.871

5.  Allergic Rhinitis Therapy Decisions During a Routine Consultation: A Multicenter, Cross-Sectional Survey.

Authors:  Gabriella Gálffy; Melanie Emmeluth; Arkady Koltun; Ferdinand Kopietz; Duc Tung Nguyen; Hans Christian Kuhl
Journal:  J Asthma Allergy       Date:  2021-04-07

6.  UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational study.

Authors:  David B Price; Glenis Scadding; Claus Bachert; Hesham Saleh; Shuaib Nasser; Victoria Carter; Julie von Ziegenweidt; Alice M S Durieux; Dermot Ryan
Journal:  NPJ Prim Care Respir Med       Date:  2016-06-23       Impact factor: 2.871

7.  The impact of perennial allergic rhinitis with/without allergic asthma on sleep, work and activity level.

Authors:  Mercedes Romano; Stephanie James; Emily Farrington; Richard Perry; Lisa Elliott
Journal:  Allergy Asthma Clin Immunol       Date:  2019-12-06       Impact factor: 3.406

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.